Inventor
DAVALIAN DARIUSH
US43 patents
⚠️ This page may combine multiple inventors who share the name “DAVALIAN DARIUSH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
DADE BEHRING MARBURG GMBH
10 patentsUS6797481B1Sep 28, 2004
Simultaneous screening of multiple analytes
DADE BEHRING MARBURG GMBH40 citations95
US6054303AApr 25, 2000
Cyclosporin immunoassay
DADE BEHRING MARBURG GMBH66 citations94
US7101682B2Sep 5, 2006
Simultaneous screening of multiple analytes
DADE BEHRING MARBURG GMBH28 citations92
US6225073B1May 1, 2001
Immunoassay for mycophenolic acid
DADE BEHRING MARBURG GMBH24 citations92
US6410696B1Jun 25, 2002
Cyclosporin immunoassay
DADE BEHRING MARBURG GMBH26 citations91
US6190873B1Feb 20, 2001
Cyclosporin assay and kit
DADE BEHRING MARBURG GMBH22 citations91
US5972630AOct 26, 1999
Homogeneous immunoassays using enzyme inhibitors
DADE BEHRING MARBURG GMBH19 citations90
US7033775B2Apr 25, 2006
Simultaneous screening of multiple analytes
DADE BEHRING MARBURG GMBH13 citations83
US6783947B1Aug 31, 2004
Protecting groups for biological labeling
DADE BEHRING MARBURG GMBH6 citations60
US5919641AJul 6, 1999
Homogeneous immunoassays using enzyme inhibitors
DADE BEHRING MARBURG GMBH1 citations50
ABBOTT CARDIOVASCULAR SYSTEMS
7 patentsUS8048448B2Nov 1, 2011
Nanoshells for drug delivery
ABBOTT CARDIOVASCULAR SYSTEMS25 citations92
US8017237B2Sep 13, 2011
Nanoshells on polymers
ABBOTT CARDIOVASCULAR SYSTEMS11 citations84
US8044021B2Oct 25, 2011
Sustained release of apo A-I mimetic peptides and methods of treatment
ABBOTT CARDIOVASCULAR SYSTEMS9 citations83
US7828996B1Nov 9, 2010
Method for the manufacture of stable, nano-sized particles
ABBOTT CARDIOVASCULAR SYSTEMS3 citations63
US8895056B2Nov 25, 2014
Regional delivery of therapeutic agents for the treatment of vascular diseases
ABBOTT CARDIOVASCULAR SYSTEMS2 citations62
US9289318B2Mar 22, 2016
Method of treatment with a bioabsorbable stent with time dependent structure and properties and regio-selective degradation
ABBOTT CARDIOVASCULAR SYSTEMS0 citations51
US7985728B1Jul 26, 2011
Sustained release of Apo A-I mimetic peptides and methods of treatment
ABBOTT CARDIOVASCULAR SYSTEMS1 citations50
MURASE KATSUYUKI
3 patentsUS8709472B1Apr 29, 2014
Bioactive agent-loaded heart-targeting nanoparticles
MURASE KATSUYUKI8 citations82
US9173890B2Nov 3, 2015
Sustained release of Apo A-I mimetic peptides and methods of treatment
MURASE KATSUYUKI2 citations61
US8735344B2May 27, 2014
Sustained release of APO A-I mimetic peptides and methods of treatment
MURASE KATSUYUKI0 citations49
DAVALIAN DARIUSH
3 patentsUS8709473B1Apr 29, 2014
Method of targeting hydrophobic drugs to vascular lesions
DAVALIAN DARIUSH5 citations70
US8273274B2Sep 25, 2012
Method for the manufacture of stable, nano-sized particles
DAVALIAN DARIUSH1 citations50
US8870847B2Oct 28, 2014
Blood vessel permeability-enhancement for the treatment of vascular diseases
DAVALIAN DARIUSH1 citations49